Biotechnology

ASTR Institute Announces at Home Pain Relief Breakthrough

May 25, 2021 10:00 AM

BOISE, ID / ACCESSWIRE / May 25, 2021 / The ASTR Institute is pleased to announce their Advanced Soft Tissue Release pain treatment program, once only available in a clinical setting, is now available for home use. ASTR is a treatment approach developed by Dr. Joseph Jacobs that treats pain at its source. This program takes less than 5 minutes a day, with easy to use medical tools and a holistic approach to healing. ASTR was created by a doctor...

Read more

Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech

May 25, 2021 8:00 AM

Pieris will receive $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties for commercialized programs Collaboration includes initial programs in respiratory disease and ophthalmology, with opportunity to nominate additional programs BOSTON, MA / ACCESSWIRE / May 25, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology...

Read more

Thermic Science Gives Financial Update and Guidance as it Announces Financials for Filings Have Been Completed Internally in Compliance with Rule 15c2-11 and OTC Market Reporting Changes

May 24, 2021 9:45 AM

NASHVILLE, TN / ACCESSWIRE / May 24, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is pleased to announce that the company's financials have been completed internally and are expected to be filed in the next 30 days. Furthermore, it is through these filings the company is compliant with the OTC rule 15c2-11 and OTC Market...

Read more

Wuhan General Group Appoints Robert "Black Tiger" Simbowe as Director of Health and Fitness

May 24, 2021 9:00 AM

CAPE TOWN, SA / ACCESSWIRE / May 24, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: The company is pleased to announce the appointment of Robert Simbowe as Director of Health and Fitness. Robert is a professional MMA fighter with the Extreme Fighting...

Read more

Dyadic to Present at Upcoming Events

May 24, 2021 8:30 AM

JUPITER, FL / ACCESSWIRE / May 24, 2021 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company will participate in the...

Read more

Alkame's Build Out of New Production Facility Nearing Operational Status

May 24, 2021 8:00 AM

LAS VEGAS, NV / ACCESSWIRE / May 24, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a diversified holding company, is pleased to announce that the buildout of its wholly-owned subsidiary West Coast Co-Packer, Inc.'s new production facility is nearing operational status. The new West Coast Copacker food and beverage manufacturing facility located in Salem Oregon will allow for business growth with additional room for further continued...

Read more

Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021

May 24, 2021 7:00 AM

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights from Digestive Disease Week (DDW) 2021 which was held May 21-23. During the 3-day virtual event, there were more than 30 different presentations featuring the use of the OverStitch™ Endoscopic Suturing System in a variety of endoscopic...

Read more

Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

May 20, 2021 9:05 AM

CAPE TOWN, SA / ACCESSWIRE / May 20, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: The company is pleased to announce the appointment of Michael Sachar as CEO of M2Bio Sciences Food & Beverage. Michael brings with him 17 years of extraordinary proprietary food and beverage...

Read more

Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

May 20, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / May 20, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, announced today that management is scheduled to participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Friday, June 4, 2021 at 1:00 PM EDT. A webcast...

Read more

Lexaria's Newest DehydraTECH(TM) 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever

May 20, 2021 7:05 AM

New formulation delivers up to 2,708% more CBD into bloodstream* Human clinical hypertension study HYPER-H21-1 also progressing KELOWNA, BC / ACCESSWIRE / May 20, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce successful test results of two new "DehydraTECH™ 2.0" cannabidiol ("CBD") formulations in its second...

Read more

Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update

May 19, 2021 9:30 AM

Significant Growth Reported in Total Revenue (121%), Instrument Sales (235%), and Consumable Products (81%); Definitive Progress Continued in the BaroFold and UST Platforms; Closure Expected Soon on Agrochemical Supplier Asset Acquisition Investor Conference Call Scheduled for Wednesday, May 19, 2021 at 4:30 p.m. EDT SOUTH EASTON, MA / ACCESSWIRE / May 19, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in...

Read more

EV Biologics Updates Shareholders on Name and Symbol Change

May 19, 2021 9:00 AM

CHEYENNE, WY / ACCESSWIRE / May 19, 2021 / EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change submission to the Financial Industry Regulatory Authority (FINRA). As some might be aware, such submissions can be a lengthy and complex process, requiring notarized documents. On April 12, 2019, the Company filed Articles of Continuance with the...

Read more

Applied UV and 3Sixty Biopharmaceuticals Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the Continent of Africa

May 19, 2021 8:30 AM

$3.5 million minimum first year purchase commitment of Airocide® systems MOUNT VERNON, NY / ACCESSWIRE / May 19, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the...

Read more

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings

May 19, 2021 8:00 AM

Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply agreement (the "Agreement") with Lobe...

Read more

Nascent Biotech and BioRay Pharmaceutical Announce $5,000,000 Exclusive License Agreement for Development and Commercialization of Nascent's Pritumumab

May 19, 2021 8:00 AM

TAIZHOU, ZHEJIANG, CHINA & SAN DIEGO, CA / ACCESSWIRE / May 19, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) and BioRay Pharmaceutical Ltd., today announced that Nascent Biotech ("Nascent" or the "Company") has entered into a license agreement (the "Agreement") with BioRay Pharmaceutical Co Ltd ("BioRay"), thereby granting to BioRay exclusive rights to commercialize Nascent's monoclonal antibody, Pritumumab, in international markets, excluding...

Read more

Viewpoint Molecular Targeting(TM) Bolsters its Board of Directors with Appointment of Charles Link, M.D., FACP

May 18, 2021 10:00 AM

Medical Oncologist and Industry Innovator With Over 20 Years of Experience in Discovery, Development and Commercialization of Oncology Therapies CORALVILLE, IA / ACCESSWIRE / May 18, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced the appointment of Charles...

Read more

With Sales Up Over 120%, Pressure BioSciences to Host Q1 2021 Financial Results and Business Update on Wednesday, May 19, 2021

May 18, 2021 9:10 AM

Q1 Financial Results Strongest Since Q4 2018; Q2 Revenue Already Exceeds Q2 2020. Purchase of Accretive, Eco-Friendly Agrochemical Supplier Nearing Close. SOUTH EASTON, MA / ACCESSWIRE / May 18, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2021 financial results and provide a business update. Anyone interested may listen to...

Read more

Experion Holdings AGM to be Hosted Virtually May 26, 2021

May 18, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / May 18, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the annual and special virtual-only meeting (the "Meeting") of holders of common shares (the "Shares") of Experion will be held on Wednesday, May 26, 2021 at 11:00 a.m. (Pacific time). Due to concerns regarding the coronavirus outbreak and to assist in protecting the health and...

Read more

Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer

May 18, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is pursuing, through its licensing arrangements, the development of a small molecule drug ("SMD") for the treatment of colon cancer. SMD is defined as any organic compound that enters cells easily because it has low molecular weight (< 900 daltons). Once inside the cells, it can affect other molecules, such as proteins, and...

Read more

Thermic Science Sends First North American Shipment of Thermic Infrared Heating Paint for N.A. Certification, Retail Consumer Sales, and Further R&D for Its Advanced Thermic Technology to Successfully Disrupt the Immense and Disadvantaged North American Power and Heating Industry

May 17, 2021 1:30 PM

NASHVILLE, TN / ACCESSWIRE / May 17, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN:A1W61J)(ISIN:US29271J1097)(OTC PINK:ENDO), is pleased to announce that the first batch of the North American Shipments of the Thermic Infrared Heating Paint has been sent for N.A. Certification, Retail Consumer Sales, and Further R&D. The Advanced Thermic Technology has several...

Read more